LobbyingFamily Research Council lobbying by quarter
Family Research Council's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Family Issues/Abortion/Adoption and Civil Rights/Civil Liberties.
Family Research Council
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $10K | 1 |
| Q1 2023 | $10K | 1 |
| Q2 2023 | $5,000 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $8,000 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Family, abortion and adoption$6,500 · 14 reports
- Defense$6,500 · 8 reports
- Health issues$4,625 · 10 reports
- Religion$4,500 · 5 reports
- Civil rights and liberties$2,625 · 13 reports
- Financial institutions and securities$2,500 · 1 reports
- Veterans$2,000 · 2 reports
- Taxation$625 · 4 reports
- Government issues$625 · 3 reports
- Constitution$625 · 2 reports
- Education$625 · 2 reports
- Homeland security$625 · 2 reports
- Science and technology$625 · 2 reports
- Foreign relations$0 · 1 reports
- Law enforcement and criminal justice$0 · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Food & Drug Administration (FDA)1 reports
- Health & Human Services, Dept of (HHS)1 reports
- Justice, Dept of (DOJ)1 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseFamily Research Council | $33K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | In-house | Under $5,000 |
| 04/16for Q1 | In-house | Under $5,000 |
| 01/20for Q4 2025 | In-house | Under $5,000 |
| 25/10/20for Q3 2025 | In-house | Under $5,000 |
| 25/07/17for Q2 2025 | In-house | $8,000 |
| 25/04/17for Q1 2025 | In-house | Under $5,000 |
| 25/01/22for Q4 2024 | In-house | Under $5,000 |
| 24/10/18for Q3 2024 | In-house | Under $5,000 |
| 24/07/18for Q2 2024 | In-house | Under $5,000 |
| 24/04/18for Q1 2024 | In-house | Under $5,000 |
| 24/04/08for Q2 2023 | In-house | $5,000 |
| 24/01/19for Q4 2023 | In-house | Under $5,000 |
| 23/11/21for Q3 2023 | In-house | Under $5,000 |
| 23/07/18for Q2 2023 | In-house | $5,000 |
| 23/04/19for Q1 2023 | In-house | $10K |
| 23/01/17for Q4 2022 | In-house | $10K |